Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience

Abstract Background Clinical trials and real-world studies revealed a spectrum of response to CGRP(-receptor) monoclonal antibodies (mAbs) in migraine prophylaxis, ranging from no effect at all to total migraine freedom. In this study, we aimed to compare clinical characteristics between super-respo...

Full description

Bibliographic Details

Published in:	The Journal of Headache and Pain
Main Authors:	Bianca Raffaelli, Mira Fitzek, Lucas H. Overeem, Elisabeth Storch, Maria Terhart, Uwe Reuter
Format:	Article
Language:	English
Published:	BMC 2023-02-01
Subjects:	Nonresponder CGRP-mAb Predictors
Online Access:	https://doi.org/10.1186/s10194-023-01552-x